Evidence map›Paper›PMID 41550446›Full record

ReviewJPRAS open2026

Bone complications after hand and face transplantation: Mechanisms and management.

Omer Dirican, Bedreddin Sazoglu, Zeynep Demir, Naga Anvesh Kodali, Ramu Janarthanan, Yalcin Kulahci, Fatih Zor, Vijay S Gorantla

Abstract readReview
In one paragraph

Review in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Omer DiricanWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Bedreddin SazogluWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Zeynep DemirWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Naga Anvesh KodaliWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Ramu JanarthananWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Yalcin KulahciDepartment of Surgery, Advocate Health, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Fatih ZorDepartment of Plastic Surgery, Indiana University, Indianapolis, IN, United States.
Vijay S GorantlaDepartment of Surgery, Advocate Health, Wake Forest University School of Medicine, Winston-Salem, NC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascularized composite allotransplantation (VCA) has expanded the frontiers of reconstructive surgery by enabling restoration of form and function in patients with devastating facial and extremity defects. While advances in surgical techniques and immunosuppression have improved short- and mid-term outcomes, bone-related complications remain a critical yet underexplored challenge. This review provides a comprehensive overview of the mechanisms and clinical manifestations of bone problems in VCA, including delayed union, nonunion, avascular necrosis, and osteoporosis. Particular emphasis is placed on the detrimental effects of long-term immunosuppressive therapy on bone metabolism and repair. Current and emerging strategies to address these issues-such as glucocorticoid-sparing regimens, pharmacological therapies like bisphosphonates and teriparatide, and regenerative medicine approaches-are also discussed. By synthesizing clinical experience, translational studies, and experimental models, this review underscores that bone complications represent a major determinant of graft integration, functional recovery, and long-term success in VCA. Greater recognition of these challenges and development of targeted management strategies are essential to optimize outcomes for recipients of bone-containing allotransplants.

Indexed as

Bone complicationsBone healingImmunosuppressionOsteonecrosisOsteoporosisVascularized composite allotransplantation

Identifiers

PMID41550446
PMCPMC12808884

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.